Multiple Sclerosis - Modern Medicine
ADVERTISEMENT
Entire Site
News
Full Articles
Welcome back,
Edit Your Profile
/
Log Out
Register
/
Log In
Allergy & Immunology
Cardiovascular Disease
Clinical Pharmacology
Cosmetic Surgery
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Infectious Disease
Internal Medicine
Locum Tenens
Managed Care & Medicare Part D
Medical Economics
Neurology
Nursing
Obstetrics/Gynecology & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology
Pediatrics
Pharmacy
Primary Care Medicine
Psychiatry & Behavioral Health
Radiology
Surgery
Surgical Video Center
Urology
All Resource Centers, Condition Centers and Reference Shelves
Coding Counselor
Formulary Counselor
Patient Education
Pay for Performance Center
Contemporary OB/GYN
Contemporary Pediatrics
Cosmetic Surgery Times
Dermatology Times
Drug Topics
Formulary
Geriatrics
Healthcare Traveler
Locum Life
Managed Healthcare Executive
Medical Economics
Ophthalmology Times
RN
Urology Times
Multiple Sclerosis
Resource Center:
Neurology
TOP STORY
Brain MRI useful for predicting risk of MS in optic neuritis
Long-term outcomes of a study of optic neuritis have shown that even one brain lesion ≥3 mm at the time of the first episode can be predictive of development of multiple sclerosis, making a brain MRI an essential part of patient management.
NEWS
Modified Mice Less Susceptible to Multiple Sclerosis
Multiple Sclerosis Drug Reduces Active Lesions
Hereditary Rickets and Multiple Sclerosis Linked
Cognitive Impairment Common in Young MS Patients
Prozac Shows Promise As Multiple Sclerosis Treatment
More News
FEATURE ARTICLES
Glatiramer effective in delaying clinical MS
Glatiramer, interferon beta-1b comparable in early RRMS
New data on progressive multifocal leukoencephalopathy with Tysabri
Brain MRI useful for predicting risk of MS in optic neuritis
From the American Academy of Neurology 59th Annual Meeting: BENEFIT: Rituximab offers early promise in the treatment of RRMS
From the American Academy of Neurology 59th Annual Meeting: BENEFIT: Better outcomes demonstrated with early versus late initiation of interferon beta-1b for MS
More Articles
CME SHOWCASE
Multiple Sclerosis Case 1: Ms T, a 24-year-old Woman With Acute Eye Pain and Decreased Vision
More CME
Clinical Practice Tools
Formulary Counselor
Search for Formularies
Coding Counselor
Search for ICD-9 Codes
Patient Education
Customize Handouts
Surgical Video Center
Videos of live procedures
SITE TOOLS
RSS Feeds
Multiple Sclerosis
More RSS feeds from
Modern Medicine
[ What's RSS? ]
[close window]
ADVERTISEMENT
Click here